India’s new system to discover end-of-day market prices got off to a confusing start, with traders trying to make sense of a spike in the NSE Nifty 50 Index stemming from the shift.

US stocks rose into the first trading day of the month as attention turned to this week’s heavy slate of earnings reports.

Players like Lamine Yamal and Jude Bellingham are Europe’s rare earths

Why has New York City Mayor Zohran Mamdani become nationally prominent so quickly? Part of it has to do with his bold and controversial policy proposals, his undeniable political skills and his wholehearted embrace of social media. But it can’t hurt that there are so many journalists in New York to

AstraZeneca tops pharma growth rankings while Bristol Myers trails amid merger talks

Pascal Soriot has an awkward relationship with the UK. Now, the boss of AstraZeneca Plc is contemplating a megadeal with US peer Bristol-Myers Squibb Co. that could shift the British drugmaker’s center of gravity further westwards. It’s a potentially tricky tie-up. But Soriot’s counterintuitive bets

FORM 8.3

FORM 8.3

Blackfin Joins Bevara Building Services: One Partner, One Invoice, One Self-Performing Relationship Across Multiple Markets.

All about oncology? A cardio workout? Patent-cliff avoidance? American dreaming?